Ennsub, the independent subsea design, engineering and technology company, has secured an order book with options in excess of £7.5 million for execution in 2014, a large proportion of which is for major international subsea ...
Tags: Ennsub, subsea design, subsea installation
Controlling dietary acid intake by increasing consumption of fruits and vegetables could help improve kidney health, according to three new studies from the US and Japan. The studies were presented at the ASN Kidney Week 2013 held at the ...
Tags: Agriculture, Food
U.S. allergists say a new long-term medication in under-the-tongue tablet form is promising and may even have the potential to cure hay fever. Officials at the American Academy of Allergy, Asthma & Immunology said allergy immunotherapy is ...
Linkage Biosciences announced the launch of the first commercially available real-time PCR KIR genotyping test at the 39th annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI). Killer cell ...
Tags: PCR KIR Test, Linkage Biosciences
The packaging manufacturing giant gained market share and benefited from the acquisition of Swedish packaging business SCA last year. Pretax profit rose to £85m, up from £55.8m in 2012, while revenue increased from ...
InnaVirVax, a biopharmaceutical company, has commenced a Phase II clinical trial evaluating the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy (ART) in the course of HIV-1 infection. The ...
Human immunodeficiency virus treatment failure is possible even in those with low viral load, researchers in Canada say. Claudie Laprise of the University of Montreal, who worked in close collaboration with doctors from the Clinique ...
Tags: Prognosis for HIV, HIV Treatment Good, Anti-Retroviral Therapy
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
Men with prostate cancer who ate a low-fat diet and took fish body oil supplements may have lower risk of cancer recurrence, U.S. researchers say. Lead author William Aronson of the University of California, Los Angeles, and chief of ...
Tags: Low-fat, diet, fish oil, supplement, prostate, cancer, recurrence
Germany-based Bayer HealthCare and US-based Onyx Pharmaceuticals have announced that the US Food and Drug Administration (FDA) has approved Nexavar (sorafenib), an oral multi-kinase inhibitor, for the treatment of patients with ...
Lower-income youth with kidney disease, even when prescribed growth hormone, are less likely to grow to a normal height, U.S. researchers say. Dr. Susan Furth, a researcher at The Children's Hospital of Philadelphia and lead author of the ...
The Nissan Altima is not a replacement for the Maxima, despite the former arriving as the latter departs. That’s the word from Nissan Australia, which reasons that the Altima is a medium car while the Maxima is a large car, despite ...
Pfizer has secured regular approval from the US Food and Drug Administration (FDA) for its Xalkori (crizotinib) capsules to treat patients with metastatic ALK-positive non-small cell lung cancer (NSCLC). The approval was based on ...
Medtronic is touting a potential advance in the cardiovascular space: a recent study that shows some of the smarter algorithms it is using in its pacemakers actually slow the development of atrial fibrillation. The MINERVA study, ...
Tags: Pacemakers, Slow Heart, Rhythm Disorder
Viteava Pharmaceuticals has announced the execution of an exclusive worldwide license to an intellectual property portfolio claiming composition of matter and/or methods of use of novel analogs and derivatives of the green tea flavonoid, ...
Tags: exclusive worldwide license, EGCG, Viteava Pharmaceuticals